John Green
Director of Finance/CFO at COGENT BIOSCIENCES, INC.
Net worth: 30 766 $ as of 30/05/2024
John Green active positions
Companies | Position | Start | End |
---|---|---|---|
COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 31/05/2018 | - |
Comptroller/Controller/Auditor | 31/05/2018 | - |
Career history of John Green
Former positions of John Green
Companies | Position | Start | End |
---|---|---|---|
DICERNA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 31/05/2014 | 25/05/2020 |
Director of Finance/CFO | 31/05/2014 | 25/05/2020 | |
MERRIMACK PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 28/02/2017 | 31/05/2018 |
FRACTYL HEALTH, INC. | Comptroller/Controller/Auditor | 31/10/2015 | 28/02/2017 |
VERASTEM, INC. | Director of Finance/CFO | 13/05/2013 | 14/04/2016 |
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Finance Group, Inc. provides financial consulting services. It offers private equity services, CFO services, consulting, interim management, corporate tax, and valuation. The company was founded by Arnold Tinter, Nicholas Nardone and Shane Caiazzo in 2000 and is headquartered in Boston, MA. | Corporate Officer/Principal | 31/10/2013 | 31/05/2014 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | 31/12/2007 | 31/08/2013 |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Director of Finance/CFO | 28/02/2011 | 30/11/2012 |
REVO BIOLOGICS INC | Director of Finance/CFO | 30/04/2002 | 31/05/2010 |
░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of John Green
College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Questrom School of Business | Masters Business Admin |
Acadia University | Undergraduate Degree |
Statistics
International
United States | 12 |
United Kingdom | 2 |
Canada | 2 |
Operational
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 4 |
Corporate Officer/Principal | 3 |
Sectoral
Health Technology | 7 |
Commercial Services | 4 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
VERASTEM, INC. | Health Technology |
COGENT BIOSCIENCES, INC. | Health Technology |
FRACTYL HEALTH, INC. | Health Technology |
Private companies | 7 |
---|---|
TSI Corp | Commercial Services |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |
rEVO Biologics, Inc.
rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Corporate Finance Group, Inc. provides financial consulting services. It offers private equity services, CFO services, consulting, interim management, corporate tax, and valuation. The company was founded by Arnold Tinter, Nicholas Nardone and Shane Caiazzo in 2000 and is headquartered in Boston, MA. | Commercial Services |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
- Stock Market
- Insiders
- John Green
- Experience